News
Although Gentamicin is already approved by the U.S. Food and Drug Administration (FDA), its use in people is limited. It can ...
June is Alzheimer's and Brain Awareness Month. Colbie Schueneman, 6, is sharing her story with KIF1A, also known as KAND.
Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.
SynaptixBio, the only company licensed to commercialise a treatment for a rare but deadly disease, welcomes the announcement but says it lacks a detailed plan The government has announced that every ...
“The vast majority of adults truly need somewhere between seven and nine hours, and we offer that range because there is a ...
A groundbreaking study has revealed that a rare gene variant, APOE3-R136S, delays the onset of Alzheimer's disease by ...
R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling ...
And he had a subtle but persistent tremor – a shakiness in his hands that was hard to explain. But Mel reassured herself with ...
8d
MedPage Today on MSNOzempic Tied to Lower Dementia Risk; Ear Wax and Parkinson's; APOE4 and ICHPeople with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and ...
A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...
A rare gene mutation that delays Alzheimer's disease does so by damping inflammatory signaling in brain-resident immune cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results